mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK

Mammalian target of rapamycin complex 1 (mTORC1) inhibitors are extensively used as immunosuppressants to prevent transplant rejection and in treatment of certain cancers. In patients, chronic treatment with rapamycin or its analogues (rapalogues) has been reported to lead to sensory hypersensitivit...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Melemedjian, Ohannes K., Khoutorsky, Arkady, Sorge, Robert E., Yan, Jin, Asiedu, Marina N., Valdez, Arely, Ghosh, Sourav, Dussor, Gregory, Mogil, Jeffrey S., Sonenberg, Nahum, Price, Theodore J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742001/
https://ncbi.nlm.nih.gov/pubmed/23607966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pain.2013.03.021
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk